Four pairs of gastric adenocarcinoma samples (stage III-IV, Her-2 negative) were used for this study to identify differentially expressed proteins involved in the development and progression of gastric cancer (Table 1). This evidence concerns the gene ERBB2 and gastric adenocarcinoma.